REGISTERED NUMBER: 08239118 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 28 FEBRUARY 2026

FOR

WELLINGTON PHARMACY LIMITED

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

J S Rahania

R Rahania

REGISTERED OFFICE:

482 Sutton Road

Walsall

West Midlands

WS5 3AZ

REGISTERED NUMBER:

08239118 (England and Wales)

ACCOUNTANTS:

Ashcrofts Accountants Limited

2 Cedargrove

Hagley

Stourbridge

West Midlands

DY9 0DR

BANKERS:

Lloyds Bank plc

3 Queen Square

Wolverhampton

West Midlands

WV1 1RF

FIXED ASSETS

Tangible assets

4

67,507

105,983

CURRENT ASSETS

Stocks

5

68,512

117,645

Debtors

6

1,381,080

1,267,096

Cash at bank and in hand

163,636

135,753

1,613,228

1,520,494

CREDITORS

Amounts falling due within one year

7

(762,166

)

(713,876

)

NET CURRENT ASSETS

851,062

806,618

TOTAL ASSETS LESS CURRENT LIABILITIES

918,569

912,601

PROVISIONS FOR LIABILITIES

9

(16,877

)

(20,816

)

NET ASSETS

901,692

891,785

CAPITAL AND RESERVES

Called up share capital

10

100

100

Retained earnings

11

901,592

891,685

SHAREHOLDERS' FUNDS

901,692

891,785

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 28 February 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 28 February 2026 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 15 October 2026 and were signed on its behalf by:

J S Rahania - Director

R Rahania - Director

1.	STATUTORY INFORMATION

Wellington Pharmacy Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Fixtures, fittings & equipment

-

20% on reducing balance

Motor vehicles

-

25% on reducing balance

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 10 (2025 - 9 ) .

4.	TANGIBLE FIXED ASSETS

Fixtures,

Freehold

fittings

Motor

property

& equipment

vehicles

Totals

£

£

£

£

COST

At 1 March 2025

22,718

311,425

20,796

354,939

Additions

-

1,600

-

1,600

Disposals

(22,718

)

-

-

(22,718

)

At 28 February 2026

-

313,025

20,796

333,821

DEPRECIATION

At 1 March 2025

-

239,614

9,342

248,956

Charge for year

-

14,495

2,863

17,358

At 28 February 2026

-

254,109

12,205

266,314

NET BOOK VALUE

At 28 February 2026

-

58,916

8,591

67,507

At 28 February 2025

22,718

71,811

11,454

105,983

5.

STOCKS

2026

2025

£

£

Stocks

68,512

117,645

6.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2026

2025

£

£

Trade debtors

127,209

123,928

Other debtors

1,119,747

1,094,135

Amounts owed by group undertakings

93,055

7,888

VAT

39,181

37,289

Prepayments and accrued income

1,888

3,856

1,381,080

1,267,096

7.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2026

2025

£

£

Trade creditors

683,672

669,342

Corporation tax

37,670

34,270

Social security and other taxes

4,061

6,051

Other creditors

682

567

Directors' loan accounts

7,629

-

Accruals and deferred income

28,452

3,646

762,166

713,876

8.	LEASING AGREEMENTS

Minimum lease payments under non-cancellable operating leases fall due as follows:

2026

2025

£

£

In more than five years

21,442

21,442

9.	PROVISIONS FOR LIABILITIES

2026

2025

£

£

Deferred tax

16,877

20,816

Deferred

tax

£

Balance at 1 March 2025

20,816

Credited during the year

(3,939

)

Balance at 28 February 2026

16,877

10.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

2026

2025

value:

£

£

50

'A' Ordinary

£1

50

50

50

'B' Ordinary

£1

50

50

100

100

11.

RESERVES

Retained

earnings

£

At 1 March 2025

891,685

Profit for the year

99,907

Dividends

(90,000

)

At 28 February 2026

901,592

12.	DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

At 28 February 2026, there was a loan to Mr J S Rahania of £4,117 (2025: £Nil). This unsecured loan is interest free and repayable on demand.

At 28 February 2026, there was a loan to Mr R Rahania of £3,512 (2025: £Nil). This unsecured loan is interest free and repayable on demand.

13.	RELATED PARTY DISCLOSURES

The company was under the control of Mr J S Rahania and Mr R Rahania throughout the current year and previous year as directors of the company and Nightchem Limited as the sole shareholder and immediate holding company.

At 28 February 2026, there was a loan to Nightchem Limited of £93,055 (2025: £7,888). This unsecured loan is interest free and repayable on demand.

At 28 February 2026, there was a loan to RJR Chem Ltd of £1,103,870 (2025: £1,093,212), a company in which Mr J S Rahania and Mr R Rahania are directors. This unsecured loan is interest free and repayable on demand.

At 28 February 2026, there was a loan to Church Street Healthcare Limited of £629 (2025: £210), a company in which Mr J S Rahania and,Mr R Rahania are directors. This unsecured loan is interest free and repayable on demand.

At 28 February 2026, there was a loan to Daychem Ltd of £15,235 (2025: £713), a company in which Mr J S Rahania and Mr R Rahania are directors. This unsecured loan is interest free and repayable on demand.

14.	ULTIMATE CONTROLLING PARTY

The ultimate parent company is Nightchem Group Limited, a company incorporated in England and Wales.